Click on a Dataset ID in the table below to learn more, and to find
out who to contact about access to these data
Dataset ID
Description
Technology
Samples
EGAD00001005001
Sequencing of tissue samples and their derived organoids from oesophageal, pancreatic and colorectal cancer patients.
Illumina HiSeq 4000
40
EGAD00001011091
Sequencing of tissue samples and their derived organoids from oesophageal, pancreatic and colorectal cancer patients. .
This dataset contains all the data available for this study on 2023-06-22.
Illumina HiSeq 4000
17
EGAD00001011092
Sequencing of tissue samples and their derived organoids from oesophageal, pancreatic and colorectal cancer patients. .
This dataset contains all the data available for this study on 2023-06-22.
Illumina HiSeq 4000
81
EGAD00001015425
Sequencing of tissue samples and their derived organoids. This dataset contains a subset of colorectal and colorectal liver metastasis samples.
Illumina HiSeq 4000
1
EGAD00001015468
Targeted gene sequencing data from cancer patient-derived organoids and their matched tumour tissue samples. Part of a study to include genomic and transcriptomic sequencing data, along with CRISPR screening data from cancer patient-derived organoids and matched tumour tissues. Some organoids were developed as part of the Human Cancer Models Initiative (HCMI) in collaboration with Cancer Research UK (CRUK). The study includes organoids derived from colorectal, oesophageal, ovarian, pancreatic, and stomach cancer samples.
HiSeq X Ten
Illumina HiSeq 4000
Illumina NovaSeq 6000
1
EGAD00001015469
Whole genome sequencing data from cancer patient-derived organoids and their matched tumour tissue samples. Part of a study to include genomic and transcriptomic sequencing data, along with CRISPR screening data from cancer patient-derived organoids and matched tumour tissues. Some organoids were developed as part of the Human Cancer Models Initiative (HCMI) in collaboration with Cancer Research UK (CRUK). The study includes organoids derived from colorectal, oesophageal, ovarian, pancreatic, and stomach cancer samples.
HiSeq X Ten
Illumina HiSeq 4000
Illumina NovaSeq 6000
1
EGAD00001015470
RNA sequencing data from cancer patient-derived organoids. Part of a study to include genomic and transcriptomic sequencing data, along with CRISPR screening data from cancer patient-derived organoids and matched tumour tissues. Some organoids were developed as part of the Human Cancer Models Initiative (HCMI) in collaboration with Cancer Research UK (CRUK). The study includes organoids derived from colorectal, oesophageal, ovarian, pancreatic, and stomach cancer samples.
Illumina HiSeq 4000
Illumina NovaSeq 6000
1
